IP Library › Granted Patent US 9,364,425
Granted Patent B2
US 9,364,425 · App. 13/800,281 · Granted Jun 14, 2016

Methods and compositions for regenerating and repairing damaged or aged tissue or organs using nonviable irradiated or lyophilized pluripotent stem cells

Inventor: Richard Burt (Chicago, IL)
A61K8/982A61K8/981A61K35/12A61K35/545A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,364,425
App. No.
13/800,281
Granted
Jun 14, 2016
Kind
B2
Abstract

Compositions and methods are provided herein for regenerating and repairing damaged or aged tissue or organs using nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods described herein provide anti-aging benefits to the skin by increasing the hydration reducing fine lines, wrinkles, and pores of the skin. Compositions and methods are also provided for promoting wound healing using lyophilized pluripotent stem cell powder. A method is provided for inducing cardiac muscle regeneration in a primate comprising delivering nonviable lethally irradiated pluripotent stem cells to damaged or aged areas of the heart. The compositions and methods include nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods utilize nonviable pluripotent stem cells in the form of a powder, such as lyophilized stem cells.

Claims (18)

1. A method for promoting wound healing in a subject, the method comprising administering a wound healing composition to a wound of a subject in need of wound healing, the wound selected from puncture, incision, laceration, ulcer, ischemia, surgical wound, bullet wound, wound from explosive device, and combinations thereof, and the wound healing composition comprising an amount of non-viable lyophilized pluripotent stem cells effective to accelerate healing of the wound, wherein the non-viable lyophilized pluripotent stem cells are in the form of non-viable intact cells and fragments and cellular contents of pluripotent stem cells.

2. The method according to claim 1 , further comprising preparing the wound healing composition by mixing non-viable pluripotent stem cells with a pharmaceutically acceptable carrier.

3. The method according to claim 1 , wherein the wound healing composition does not include conditioned media.

4. The method according to claim 1 , wherein the wound healing composition is administered to the wound in an amount effective to accelerate wound closure as compared to a wound not treated with the wound healing composition.

5. The method according to claim 1 , wherein the wound healing composition further comprises an antimicrobial agent.

6. A method for promoting wound healing in a subject, the method comprising administering a wound healing composition to a wound of a subject in need of wound healing, the wound including an acute internal injury selected from puncture, incision, laceration, ulcer, ischemia, surgical wound, bullet wound, wound from explosive device, and combinations thereof, and the wound healing composition comprising an amount of non-viable lyophilized pluripotent stem cells effective to accelerate healing of the wound and a pharmaceutically acceptable carrier, wherein the non-viable lyophilized pluripotent stem cells are in the form of non-viable intact cells.

7. The method according to claim 6 , further comprising preparing the wound healing composition by mixing non-viable lyophilized pluripotent stem cells with a pharmaceutically acceptable carrier.

8. The method according to claim 6 , wherein the wound healing composition does not include conditioned media.

9. The method according to claim 6 , wherein the wound healing composition is administered to the wound in an amount effective to accelerate wound closure as compared to a wound not treated with the wound healing composition.

10. The method according to claim 1 , wherein administering the wound healing composition to the wound comprises applying the wound healing composition as a component of a bandage, transdermal patch, or bioadhesive.

11. The method according to claim 1 , wherein administering the wound healing composition to the wound comprises injecting the wound healing composition into the wound or its penumbra.

12. The method according to claim 6 , wherein administering the wound healing composition to the wound comprises applying the wound healing composition as a component of a bandage, transdermal patch, or bioadhesive.

13. The method according to claim 6 , wherein administering the wound healing composition to the wound comprises injecting the wound healing composition into the wound or its penumbra.

14. A method for promoting wound healing in an organ of a subject, the method comprising administering a wound healing composition to a wounded organ of a subject in need of wound healing, the wound selected from abrasion, cut, puncture, incision, laceration, ulcer, ischemia, surgical wound, bullet wound, wound from explosive device, and combinations thereof, and the wound healing composition comprising (1) non-viable lyophilized pluripotent stem cells in an amount effective to improve organ function and (2) a pharmaceutically acceptable carrier, wherein the non-viable lyophilized pluripotent stem cells are in the form of non-viable intact cells and fragments and cellular contents of pluripotent stem cells.

15. The method according to claim 14 , further comprising preparing the wound healing composition by mixing non-viable lyophilized pluripotent stem cells with a pharmaceutically acceptable carrier.

16. The method according to claim 14 , wherein the wound healing composition does not include conditioned media.

17. The method according to claim 14 , wherein administering the wound healing composition to the wound comprises applying the wound healing composition as a component of a bioadhesive.

18. The method according to claim 14 , wherein administering the wound healing composition to the wound comprises injecting the wound healing composition into the wounded organ or its penumbra.

Continuity (2)
Provisional Application 61612716 · Mar 19, 2012
Related Publication 20130243739A1 · Sep 19, 2013